Pacira Biosciences Inc reports results for the quarter ended in March - Earnings Summary

Pacira Biosciences

07/05/2024 22:22

* Pacira Biosciences Inc  PCRX.OQ  reported quarterly
adjusted
earnings of 62 cents​​ per share for the quarter ended in March,
higher than the same quarter last year, when the company
reported EPS of 53 cents.  The mean expectation of ten analysts
for the quarter was for earnings of 62 cents per share. Wall
Street expected results to range from 53 cents to 80 cents per
share.
    * Revenue rose 4.2% to $167.12 million from a year ago;
analysts
expected $164.82 million. 
    * Pacira Biosciences Inc's reported EPS for the quarter was
19
cents​.
    * The company reported quarterly net income of $8.98
million.
    * Pacira Biosciences Inc shares had fallen by 9.3% this
quarter and lost 21.5% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 16%
in the last three months.​ 
    * In the last 30 days, one analyst negatively revised an
earnings
estimate

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * Wall Street's median 12-month price target for Pacira
Biosciences Inc is $45.00 

This summary was machine generated from LSEG data May 7 at 09:22
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      0.62           0.62           Met
 Dec. 31 2023      0.88           0.89           Beat
 Sep. 30 2023      0.78           0.72           Missed
 Jun. 30 2023      0.76           0.78           Beat